Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum
Randomized clinical trials have shown that pramipexole has an antidepressant effect in patients with Parkinson's disease. We investigated the comparative efficacy of pramipexole toward dopamine receptor D2 and D3 expression in rat brain. Groups of rats were treated subacutely with pramipexole (...
Saved in:
Main Authors: | Naohito Tokunaga (Author), Mohammed Emamussalehin Choudhury (Author), Noriko Nishikawa (Author), Masahiro Nagai (Author), Tomoaki Tujii (Author), Hirotaka Iwaki (Author), Mika Kaneta (Author), Masahiro Nomoto (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zonisamide Increases Dopamine Turnover in the Striatum of Mice and Common Marmosets Treated With MPTP
by: Hayato Yabe, et al.
Published: (2009) -
Zonisamide Attenuates MPTP Neurotoxicity in Marmosets
by: Mohammed Emamussalehin Choudhury, et al.
Published: (2010) -
Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease
by: Rina Ando, et al.
Published: (2018) -
Conservation of the Direct and Indirect Pathway Dichotomy in Mouse Caudal Striatum With Uneven Distribution of Dopamine Receptor D1- and D2-Expressing Neurons
by: Kumiko Ogata, et al.
Published: (2022) -
Dopamine inhibits the expression of proinflammatory cytokines of microglial cells through the formation of dopamine quinone in the mouse striatum
by: Yasuhiro Yoshioka, et al.
Published: (2022)